Plain-English translation of NCT07503808 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called , which is designed to treat advanced cancers that have spread or come back after other treatments. The medication works by targeting specific markers found on certain cancer cells. Researchers want to find the right dose and learn how safe and effective this treatment is for people with various types of solid tumors.
Many patients with advanced cancers run out of standard treatment options or stop responding to them. This medication targets cancer cells in a new way, and this trial exists to see whether it can help patients whose tumors have these specific markers and have stopped responding to previous treatments.
You likely qualify if…
You likely don't qualify if…
The trial has two phases. In the first phase, small groups of participants will receive increasing doses of the medication to find the safest and most effective dose. In the second phase, more participants will receive the medication at the doses determined to be safe in phase one, so researchers can better understand how well it works. Throughout the trial, you will have regular clinic visits for blood tests, imaging scans, and checkups to monitor how you are responding to treatment and any side effects you experience.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
United States